KR880010438A - 전자부품용 동복강선 및 그 제조방법 - Google Patents

전자부품용 동복강선 및 그 제조방법 Download PDF

Info

Publication number
KR880010438A
KR880010438A KR870001625A KR870001625A KR880010438A KR 880010438 A KR880010438 A KR 880010438A KR 870001625 A KR870001625 A KR 870001625A KR 870001625 A KR870001625 A KR 870001625A KR 880010438 A KR880010438 A KR 880010438A
Authority
KR
South Korea
Prior art keywords
wire
oxygen
free
copper
electronic parts
Prior art date
Application number
KR870001625A
Other languages
English (en)
Other versions
KR900006338B1 (ko
Inventor
황성박
Original Assignee
황성박
대아리드선 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 황성박, 대아리드선 주식회사 filed Critical 황성박
Publication of KR880010438A publication Critical patent/KR880010438A/ko
Application granted granted Critical
Publication of KR900006338B1 publication Critical patent/KR900006338B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음

Description

전자부품용 동복강선 및 그 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도의 가) 나) 는 본 발명의 실시예를 설명키 위한 설명도,
제2도는 제1도에 의해 완성된 본 발명의 단면도,
제3도의 가) 나)는 타실시예를 설명키 위한 설명도.

Claims (4)

  1. Fe 선(1) 외주면에 무산소 Cu파이프(2)를 끼워 용착시켜서 된 전자부품용 동복강선.
  2. 제1항 기재에 있어서, Fe선(1) 외주면에 무산소 Fe테이프(2′)를 씌워 용착시켜서 된 전자부품용 동복강선.
  3. Fe선(1) 외주면에 무산소 Cu파이프(2)를 끼워 용착시키면서 압출시킴을 특징으로 하는 전자부품용 동복강선의 제조방법.
  4. 제3항 기재에 있어서, 무산소Cu파이프(2) 대신에 무산소 테이프(2)를 Fe선(1) 외주면에 씌워서 됨을 특징으로 하는 전자부품용 동복강선의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870001623A 1986-02-26 1987-02-25 인체 비소형세포 폐암 및 기타 인체암 치료용 모노클로날 항체 및 항원 KR900006338B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
US834172 1986-02-26

Publications (2)

Publication Number Publication Date
KR880010438A true KR880010438A (ko) 1988-10-08
KR900006338B1 KR900006338B1 (ko) 1990-08-28

Family

ID=25266276

Family Applications (2)

Application Number Title Priority Date Filing Date
KR870001623A KR870008026A (ko) 1986-02-26 1987-02-25 인체 비소형세포 폐암 및 기타 인체암 치료용 모노클로날항체 및 항원
KR1019870001623A KR900006338B1 (ko) 1986-02-26 1987-02-25 인체 비소형세포 폐암 및 기타 인체암 치료용 모노클로날 항체 및 항원

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR870001623A KR870008026A (ko) 1986-02-26 1987-02-25 인체 비소형세포 폐암 및 기타 인체암 치료용 모노클로날항체 및 항원

Country Status (28)

Country Link
US (1) US5185432A (ko)
JP (1) JPS62220197A (ko)
KR (2) KR870008026A (ko)
CN (1) CN87100927A (ko)
AT (1) AT400577B (ko)
AU (1) AU612967B2 (ko)
BE (1) BE1000611A5 (ko)
CA (1) CA1312025C (ko)
CH (1) CH675880A5 (ko)
DD (2) DD266028A5 (ko)
DE (1) DE3705276A1 (ko)
DK (1) DK98187A (ko)
ES (1) ES2004245A6 (ko)
FI (1) FI870764A (ko)
FR (1) FR2596062B1 (ko)
GB (1) GB2186885B (ko)
GR (1) GR870294B (ko)
IE (1) IE60286B1 (ko)
IT (1) IT1203511B (ko)
LU (1) LU86786A1 (ko)
NL (1) NL8700415A (ko)
NO (1) NO174719C (ko)
NZ (1) NZ219338A (ko)
OA (1) OA08485A (ko)
PT (1) PT84370B (ko)
SE (2) SE467988B (ko)
YU (1) YU46189B (ko)
ZA (1) ZA869494B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
WO2001018021A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
NZ602161A (en) 2010-03-04 2014-12-24 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
JPWO2012036094A1 (ja) * 2010-09-17 2014-02-03 独立行政法人産業技術総合研究所 肺癌鑑別マーカー
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
KR102514317B1 (ko) 2016-04-15 2023-03-27 마크로제닉스, 인크. 신규 b7-h3-결합 분자, 그것의 항체 약물 콘쥬게이트 및 그것의 사용 방법
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies

Also Published As

Publication number Publication date
ATA43587A (de) 1995-06-15
DK98187A (da) 1987-08-27
GB2186885A (en) 1987-08-26
CN87100927A (zh) 1988-10-05
LU86786A1 (fr) 1987-09-15
SE9201529D0 (sv) 1992-05-14
IE870487L (en) 1987-08-26
AU612967B2 (en) 1991-07-25
BE1000611A5 (fr) 1989-02-21
FI870764A (fi) 1987-08-27
IT8719491A0 (it) 1987-02-25
ES2004245A6 (es) 1988-12-16
FR2596062B1 (fr) 1990-06-08
IT1203511B (it) 1989-02-15
PT84370B (pt) 1989-11-10
DD266028A5 (de) 1989-03-22
FR2596062A1 (fr) 1987-09-25
US5185432A (en) 1993-02-09
SE8700805D0 (sv) 1987-02-25
ZA869494B (en) 1987-10-28
YU25787A (en) 1990-12-31
KR870008026A (ko) 1987-09-23
DK98187D0 (da) 1987-02-25
GB8703700D0 (en) 1987-03-25
NZ219338A (en) 1991-11-26
KR900006338B1 (ko) 1990-08-28
NO870770D0 (no) 1987-02-25
NO174719B (no) 1994-03-14
NO870770L (no) 1987-08-27
FI870764A0 (fi) 1987-02-23
DD276165A5 (de) 1990-02-14
DE3705276A1 (de) 1987-08-27
IE60286B1 (en) 1994-06-29
SE467988B (sv) 1992-10-12
AU6927287A (en) 1987-08-27
OA08485A (fr) 1988-07-29
GR870294B (en) 1987-06-30
GB2186885B (en) 1990-10-03
CH675880A5 (ko) 1990-11-15
SE8700805L (sv) 1987-10-22
YU46189B (sh) 1993-05-28
NL8700415A (nl) 1987-09-16
AT400577B (de) 1996-01-25
PT84370A (en) 1987-03-01
CA1312025C (en) 1992-12-29
SE9201529A0 (sv) 1992-05-14
NO174719C (no) 1994-06-22
JPS62220197A (ja) 1987-09-28

Similar Documents

Publication Publication Date Title
KR880010438A (ko) 전자부품용 동복강선 및 그 제조방법
EP0122619A3 (en) Composite product having patterned metal layer and process
EP0459773A3 (en) Semiconductor device and method for producing the same
KR850000137A (ko) 평각절연전선의 제조방법
ATE207689T1 (de) Verfahren zur herstellung von abstandshaltern auf einer elektrischen leiterplatte
KR910007118A (ko) 핀과 반도체 칩사이에 개선된 연결을 갖는 집적 장치 및 그의 제조 방법
KR900009196A (ko) 와이어 방전 가공장치의 위치 결정방법
JPS53128687A (en) Vibration-damping and sound insulating board having excellent spot welding property
KR830003267A (ko) 경납땜 수리방법
KR900015376A (ko) 용착 스크린을 사용한 나선형 도파관 형성방법
DE59100461D1 (de) Ätzlösung.
KR870011022A (ko) 코일권선의 접속방법
FR2418275A1 (fr) Alliage d'aluminium resistant a la corrosion
KR840004803A (ko) 시계 케이스의 제조방법
ES406678A1 (es) Metodo para unir alambres hechos de un material compuesto.
JPS5626687A (en) Production for copper-aluminum composite material
JPS6484690A (en) Printed wiring board and the production thereof
KR870001804A (ko) 악세사리의 제조방법
KR880010437A (ko) 전자부품용 리드선 제조방법
KR890003971A (ko) 악세사리용 다중층 와이어 제조방법
KR860002990A (ko) 악세사리의 제조방법
KR910005431A (ko) 집적회로장치 및 그 제조방법
KR850001845A (ko) 인조금속의 제조방법
KR930013203A (ko) 비드와이어 제조방법
JPS52114992A (en) Connecting method of metal wire clad cable

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application